Legend Biotech Corp - ADR

NASDAQ:LEGN  
42.61
+3.26 (+8.28%)
Earnings Announcements

Legend Biotech Posts Q4 Loss Per Share $0.30

Published: 03/18/2022 20:15 GMT
Legend Biotech Corp - ADR (LEGN) - Legend Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights.
Q4 Loss per Share $0.30.
Q4 Revenue $39 Million.
As of Dec 31, 2021, Co Had Approximately $887.1 Million of Cash and Cash Equivalents, Deposits and Short-term Investments.
Revenue is expected to be $25 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $26.96 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.